Literature DB >> 9398260

A new type of DNA minor-groove complex: carbazole dication-DNA interactions.

F A Tanious1, D Ding, D A Patrick, R R Tidwell, W D Wilson.   

Abstract

The effect of opportunistic infections (OI) on immune-compromised populations has been known for decades, but the recent AIDS epidemic has sparked renewed interest in the development of new anti-OI agents. The mechanism of action of a series of cationic unfused-aromatic anti-OI drugs is believed to involve binding of the drug to AT sequences in the minor groove of DNA. Some new anti-OI drug candidates have been synthesized with fused aromatic ring systems (e.g. carbazoles) that do not resemble the classical paradigm for minor-groove interactions at AT sequences in DNA. To characterize the DNA interactions of these compounds, we have used UV-vis absorbance, fluorescence, kinetic measurements, and circular dichroism in conjunction with NMR spectroscopy to evaluate the structure of the complexes formed between the carbazoles and DNA. Application of these methods to carbazoles substituted at either the 3,6 or 2,7 positions with cationic imidazoline groups gave conclusive, but very surprising, evidence that both compounds bind strongly in the minor groove at AT DNA sequences. NMR and molecular modeling of the complexes formed between the 3,6- and 2,7-carbazoles and the self-complementary oligomer d(GCGAATTCGC) have been used to establish structural details for the minor-groove complex. These results have been used as constraints for molecular modeling calculations to construct models of the minor-groove-carbazole complexes and to draw conclusions regarding the molecular basis for the effects of substituent position on carbazole-DNA affinities. The surprising result is that the 2,7 carbazole binds in AT sequences with hydrogen bonds involving one imidazoline group and the carbazole NH. The 3,6-carbazole compound binds in a more "classical" model that uses both imidazoline groups for H-bonding while the carbazole NH points out of the minor groove. The carbazoles thus form a new type of DNA minor groove complex and their excellent biological activities indicate that a variety of fused-ring minor-groove binding agents should be investigated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398260     DOI: 10.1021/bi971599r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Sequence-specific minor groove binding by bis-benzimidazoles: water molecules in ligand recognition.

Authors:  Christian Bailly; Gianni Chessari; Carolina Carrasco; Alexandra Joubert; John Mann; W David Wilson; Stephen Neidle
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

Review 2.  Pseudomonas biofilm matrix composition and niche biology.

Authors:  Ethan E Mann; Daniel J Wozniak
Journal:  FEMS Microbiol Rev       Date:  2012-01-23       Impact factor: 16.408

3.  Novel linear triaryl guanidines, N-substituted guanidines and potential prodrugs as antiprotozoal agents.

Authors:  Reem K Arafa; Mohamed A Ismail; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Eur J Med Chem       Date:  2008-02-29       Impact factor: 6.514

4.  Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.

Authors:  B L Blagburn; K L Drain; T M Land; R G Kinard; P H Moore; D S Lindsay; D A Patrick; D W Boykin; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

5.  Molecular characterization of recombinant Pneumocystis carinii topoisomerase I: differential interactions with human topoisomerase I poisons and pentamidine.

Authors:  Rukiyah T van Dross; Marilyn M Sanders
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

6.  Photosensitive and pH-dependent activity of pyrazine-functionalized carbazole derivative as promising antifungal and imaging agent.

Authors:  Agnieszka Chylewska; Aleksandra M Dąbrowska; Sandra Ramotowska; Natalia Maciejewska; Mateusz Olszewski; Maciej Bagiński; Mariusz Makowski
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.